Screener
LivaNova LIVN Neuromodulation — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: LivaNova’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001639691-26-000090
FAQ
- What is LivaNova's neuromodulation — total assets?
- LivaNova (LIVN) reported neuromodulation — total assets of $651.78M in Q2 2026.
- How has LivaNova's neuromodulation — total assets changed year-over-year?
- LivaNova's neuromodulation — total assets increased by 2.2% year-over-year, from $637.72M to $651.78M.
- What is the long-term trend for LivaNova's neuromodulation — total assets?
- Over 4 years (2021 to 2025), LivaNova's neuromodulation — total assets has grown at a -0.4% compound annual growth rate (CAGR), from $2.6B to $2.56B.
- What does neuromodulation — total assets mean?
- The total value of resources controlled by the Neuromodulation segment, including inventory, property, plant, equipment, and intangible assets. This metric provides insight into the capital intensity and asset base supporting the segment's operations.
Ask your AI about LivaNova's neuromodulation — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude